Docmode Health Technologies Ratios

Docmode Health Technologies Ltd Ratios

The Docmode Health Technologies Ltd Ratios page provides a complete fundamental analysis of Docmode Health Technologies Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Docmode Health Technologies Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Docmode Health Technologies Ltd (NSE: DHTL, BSE: 79225) is currently trading at ₹40.50, with a market capitalization of ₹127.28M. As a major player in the Technology services sector and Internet software/Services industry, Docmode Health Technologies Ltd remains a key stock for fundamental analysis using Docmode Health Technologies Ltd Ratios.

Docmode Health Technologies Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Docmode Health Technologies Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Docmode Health Technologies Ltd Ratios.

Historically, the Docmode Health Technologies Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The decline in Docmode Health Technologies Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Docmode Health Technologies Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Docmode Health Technologies Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Docmode Health Technologies Ltd P/S ratio currently stands at 0, an important part of Docmode Health Technologies Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

A stable or declining Docmode Health Technologies Ltd P/S ratio indicates cautious market sentiment.

Docmode Health Technologies Ltd Price to Cash Flow Ratio (P/CF)

The Docmode Health Technologies Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Docmode Health Technologies Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The declining Docmode Health Technologies Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Docmode Health Technologies Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Docmode Health Technologies Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Docmode Health Technologies Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Docmode Health Technologies Ltd EV/EBITDA ratio is currently 0, a key metric in Docmode Health Technologies Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Stable Docmode Health Technologies Ltd EV/EBITDA indicates balanced valuation.

Docmode Health Technologies Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Docmode Health Technologies Ltd D/E ratio is currently 0.82, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.82
• 2023: 0.88
• 2022: 2.44
• 2021: 3.49

Docmode Health Technologies Ltd maintains moderate leverage with manageable risk.

Return on Equity (ROE %)

The Docmode Health Technologies Ltd ROE currently stands at -21.65%, showing profitability and capital efficiency.

Historical ROE:

• 2024: -21.65
• 2023: 2.71
• 2022: 80.13
• 2021: 99.55

Declining ROE indicates pressure on profitability.

Docmode Health Technologies Ltd Ratios Analysis Summary

The Docmode Health Technologies Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Docmode Health Technologies Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Docmode Health Technologies Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.